Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Gilead Sciences, Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $91.1 Billion
- Q4 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 300,074 shares of GILD stock, worth $33.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
300,074
Previous 373,760
19.71%
Holding current value
$33.4 Million
Previous $31.3 Million
11.53%
% of portfolio
0.03%
Previous 0.03%
Shares
34 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.8 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.97 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.71 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.44 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $139B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...